AKT1 and cancer: Professor Zhao’s group also found p53 and AKT to be key factors in suppressing spontaneous apoptosis in ALT cells, which points to the inhibition of p53 and AKT as a new therapeutic approach that specifically targets ALT cancers (Ge et al., 2019).